Sunshine Biopharma Inc Warrant
SBFMW
1 hedge funds and large institutions have $1.79K invested in Sunshine Biopharma Inc Warrant in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0.05% more ownership
Funds ownership: 0.73% → 0.78% (+0.05%)
0% more funds holding
Funds holding: 1 → 1 (0)
39% less capital invested
Capital invested by funds: $2.94K → $1.79K (-$1.15K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$197 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $1.79K | +$197 | +1,396 | +6% |
|
SBFMW Hedge Fund Activity: Q1 2026 in Review
1 of the 8,143 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q1 2026, worth a combined $1.79K — down 39% from $2.94K a quarter earlier.
Fund positioning in SBFMW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $197.
- 1 institutional investor held Sunshine Biopharma Inc Warrant (SBFMW) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $1.79K of Sunshine Biopharma Inc Warrant stock for Q1 2026, down 39% quarter-over-quarter.
- 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q1 2026 and 0 closed out.
- The largest Sunshine Biopharma Inc Warrant buyer in Q1 2026 was UBS Group, an estimated $197 added.
Based on aggregated 13F filings for Q1 2026.